The quintessential form of diastolic heart failure in older adults: Wild type transthyretin cardiac amyloidosis.


Journal

Clinical cardiology
ISSN: 1932-8737
Titre abrégé: Clin Cardiol
Pays: United States
ID NLM: 7903272

Informations de publication

Date de publication:
Feb 2020
Historique:
received: 21 08 2019
revised: 08 10 2019
accepted: 08 11 2019
pubmed: 12 12 2019
medline: 28 10 2020
entrez: 12 12 2019
Statut: ppublish

Résumé

Wild-type transthyretin cardiac amyloidosis (ATTRwt) is now recognized as a common cause of heart failure with preserved ejection fraction (HFpEF). In this review, we aim to describe the unique epidemiologic, pathophysiologic, and clinical features associated with ATTwt cardiac amyloidosis. Compared to other etiologies of HFpEF, ATTRwt cardiac amyloidosis affects almost exclusively older adults, demonstrating a characteristic age-dependent penetrance that impacts both the diagnosis and treatment of the disease. In addition, ATTR cardiac amyloidosis demonstrates a unique pathophysiology in contrast to other etiologies of HFpEF, which results in a characteristic phenotype that can raise suspicion for ATTRwt cardiac amyloid in the appropriate demographic. With these distinguishing features in mind, we aim to describe the specific signs, symptoms, and imaging characteristics associated with ATTRwt cardiac amyloidosis, including the role of nuclear scintigraphy that has essentially eliminated the need for biopsy in most patients with suspected disease. Finally, we review the evidence behind the available therapeutic agents, as well as those under investigation, which will change the way we manage older patients with ATTRwt cardiac amyloidosis in the coming years.

Identifiants

pubmed: 31825134
doi: 10.1002/clc.23301
pmc: PMC7021652
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

171-178

Informations de copyright

© 2019 The Authors. Clinical Cardiology published by Wiley Periodicals, Inc.

Références

Circulation. 2016 Jun 14;133(24):2404-12
pubmed: 27143678
Eur Heart J. 2015 Oct 7;36(38):2585-94
pubmed: 26224076
Amyloid. 2006 Dec;13(4):236-49
pubmed: 17107884
Circulation. 2012 Sep 4;126(10):1286-300
pubmed: 22949539
Rev Esp Cardiol (Engl Ed). 2017 Nov;70(11):991-1004
pubmed: 28870641
Amyloid. 2006 Sep;13(3):164-9
pubmed: 17062383
Curr Med Res Opin. 2013 Jan;29(1):63-76
pubmed: 23193944
Amyloid. 2019 Sep;26(3):156-163
pubmed: 31210553
Mod Pathol. 2015 Feb;28(2):201-7
pubmed: 25189643
N Engl J Med. 1997 Sep 25;337(13):898-909
pubmed: 9302305
Circ Heart Fail. 2018 Apr;11(4):e004769
pubmed: 29615436
N Engl J Med. 2018 Jul 5;379(1):11-21
pubmed: 29972753
J Am Coll Cardiol. 2016 Jul 12;68(2):161-72
pubmed: 27386769
Aging health. 2013 Apr 1;9(2):229-235
pubmed: 24073013
Sci Transl Med. 2011 Aug 24;3(97):97ra81
pubmed: 21865539
JACC Basic Transl Sci. 2018 Dec 31;3(6):871-873
pubmed: 30623146
Science. 2001 Sep 28;293(5539):2459-62
pubmed: 11577236
Eur Heart J. 2017 Oct 7;38(38):2879-2887
pubmed: 29019612
Circ Heart Fail. 2011 Mar;4(2):121-8
pubmed: 21191093
Circ Cardiovasc Imaging. 2016 Aug;9(8):
pubmed: 27511979
J Neurol. 2017 Feb;264(2):268-276
pubmed: 27878441
Ups J Med Sci. 2014 Aug;119(3):223-8
pubmed: 24620715
JAMA. 2017 Sep 12;318(10):962-963
pubmed: 28898370
J Am Coll Cardiol. 2016 Sep 6;68(10):1014-20
pubmed: 27585505
Eur Heart J. 2016 Dec 14;37(47):3525-3531
pubmed: 26908951
Proc Natl Acad Sci U S A. 2013 Jun 11;110(24):9992-7
pubmed: 23716704
JACC Cardiovasc Imaging. 2016 Mar;9(3):325-7
pubmed: 26189123
Eur Heart J. 2017 Jun 21;38(24):1895-1904
pubmed: 28329248
Circ Cardiovasc Imaging. 2013 Mar 1;6(2):195-201
pubmed: 23400849
Amyloid. 2011 Jun;18 Suppl 1:196-7
pubmed: 21838485
Am J Med. 1983 Oct;75(4):618-23
pubmed: 6624768
N Engl J Med. 2019 Jan 10;380(2):196-197
pubmed: 30625051
Circulation. 2015 Oct 20;132(16):1570-9
pubmed: 26362631
JACC Cardiovasc Imaging. 2020 Jan;13(1 Pt 1):69-80
pubmed: 31202744
Clin Cardiol. 2020 Feb;43(2):171-178
pubmed: 31825134
Heart Fail Rev. 2015 Mar;20(2):117-24
pubmed: 25758359
Circ Heart Fail. 2019 Jun;12(6):e006169
pubmed: 31172792
Amyloid. 2014 Mar;21(1):35-44
pubmed: 24455993
Am J Cardiol. 1985 Jun 1;55(13 Pt 1):1645
pubmed: 4003314
N Engl J Med. 2018 Jul 05;379(1):22-31
pubmed: 29972757
JACC Heart Fail. 2014 Apr;2(2):113-22
pubmed: 24720917
JAMA Cardiol. 2016 Nov 1;1(8):880-889
pubmed: 27557400
Proc Natl Acad Sci U S A. 2012 Jun 12;109(24):9629-34
pubmed: 22645360
Hum Pathol. 2011 Nov;42(11):1785-91
pubmed: 21733562
Amyloid. 2017 Dec;24(4):226-230
pubmed: 28906148
Am J Cardiol. 2014 Oct 1;114(7):1089-93
pubmed: 25212550
N Engl J Med. 2006 Jul 20;355(3):251-9
pubmed: 16855265
Curr Cardiovasc Risk Rep. 2017 Jun;11:
pubmed: 29057029
J Am Coll Cardiol. 2005 Sep 20;46(6):1076-84
pubmed: 16168294

Auteurs

Elissa Driggin (E)

Department of Medicine, Columbia University Irving Medical Center, New York, New York.

Mathew S Maurer (MS)

Division of Cardiology, Department of Medicine, Columbia University Irving Medical Center, New York, New York.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH